| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Animal Model |
From the Department of Laboratory Medicine and Pathology, MayoClinic, Rochester, Minnesota
Most spontaneously developing hyperplastic and neoplastic
lesions of the pituitary occur in the anterior pituitary. Targeted
disruption of various cell-cycle proteins, including
Rb, p27kip1 (p27), and p18INK4c
(p18), is associated with intermediate lobe pituitary
hyperplasia. To develop a model of anterior pituitary proliferation to
study the pathogenesis of pituitary tumors, we crossed the
glycoprotein hormone
-subunit (
SU)-null mice that develop
thyroid-stimulating hormone (TSH) cell hyperplasia with
p18-null mice. The resulting offsprings developed accelerated
enlargement of the anterior lobe with predominantly TSH cell
hyperplasia. Immunohistochemical and histological analyses of these
mice along with p27/p18 double-null mice, p18-null
mice, and p27-null mice showed evidence of TSH,
adrenocorticotropic hormone, prolactin, and luteinizing
hormone hyperplasia. To determine whether there were alterations of p27
and the target proteins implicated in the ubiquitin degradation of p27
and other cyclin-dependent kinase inhibitors, we examined
expression of SKP 2, Grb 2, and Jab 1 in the
pituitaries of null mice. In the
SU-null mice there were decreased
levels of SKP 2 and elevated levels of Grb 2 expression by Western blot
analysis. Immunohistochemical analysis of the pituitary showed elevated
Grb 2 in
SU-null and p18/
SU double-null mice. Jab 1 levels were
not different from controls in the pituitary. These results show that
1) the p18/
SU double-null mice represent a good model to study the
rapid development of anterior pituitary hyperplasia, and 2)
various proteins important in p27 and other cyclin-dependent kinase
inhibitor protein degradation are altered in the pituitary of
SU-null and p18/
SU double-null mouse models.
This article has been cited by other articles:
![]() |
A. Ribeiro-Oliveira Jr, G. Franchi, B. Kola, P. Dalino, S. V. B. Pinheiro, N. Salahuddin, M. Musat, M. I Goth, S. Czirjak, Z. Hanzely, et al. Protein western array analysis in human pituitary tumours: insights and limitations Endocr. Relat. Cancer, December 1, 2008; 15(4): 1099 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Riss, L. Jin, X. Qian, J. Bayliss, B. W. Scheithauer, W. F. Young Jr., S. Vidal, K. Kovacs, A. Raz, and R. V. Lloyd Differential Expression of Galectin-3 in Pituitary Tumors Cancer Res., May 1, 2003; 63(9): 2251 - 2255. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |